30.12.2012 Views

Pharmaceutical Manufacturing Handbook: Production and

Pharmaceutical Manufacturing Handbook: Production and

Pharmaceutical Manufacturing Handbook: Production and

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

TABLE 2 FDA Registered Oral ER Formulations Containing Commonly Used<br />

Excipients in Hydrophilic Matrix Tablets<br />

Hydrophilic Polymer<br />

a<br />

Hydroxypropyl methyl<br />

cellulose [24]<br />

Hydroxypropylcellulose<br />

[120, 121]<br />

Polyethylene oxide [68, 128]<br />

Sodium alginate [134]<br />

Xanthan gum [125, 137 – 140]<br />

Hydroxyethyl cellulose<br />

[117 – 119]<br />

Carbomer [129]<br />

Methyl cellulose [121]<br />

shown that degradation of PEO to lower molecular weight might occur due to the<br />

high temperature used in the extruder. Extrusion to small pellets based on hydrophilic<br />

polymers hydroxyethyl cellulose (HEC) <strong>and</strong> HPMC has been performed, <strong>and</strong><br />

isopropyl alcohol instead of water was used to avoid lump formation [12] . Also<br />

Carbopol [14 – 16] , pectin [114] , <strong>and</strong> xanthan [115, 116] have been extruded <strong>and</strong> used<br />

as matrix carrier materials for extended release.<br />

The choice of hydrophilic polymer is one determining factor for the drug release<br />

rate, as discussed above. The most common type used for hydrophilic matrix systems<br />

is HPMC (hypromellose, hydroxypropyl methyl cellulose) [24, 83] but some alternatives<br />

are HEC [117 – 119] , HPC [120, 121] , methyl cellulose [121] , xanthan [122 – 127] ,<br />

PEO [68, 128] , Carbopol [129 – 131] , pectin [131 – 133] , <strong>and</strong> alginate [134 – 136] ; see<br />

Table 2 . HPMCs are available in several approved degrees of substitution [60] . To<br />

achieve different release durations, different viscosity grades of the polymers may<br />

be used (the higher the viscosity grade, the slower the release rate). If the desired<br />

viscosity is not available, one can mix two polymer grades with different viscosity<br />

grades [68] .<br />

6.8.5<br />

COMPARISON AND SUMMARY OF DIFFERENT TECHNOLOGIES 1211<br />

Fraction of<br />

Excipient (%)<br />

10 – 80<br />

15 – 35<br />

5 – 85<br />

5 – 50<br />

10 – 99<br />

40 – 97.5<br />

20 – 75<br />

5 – 75<br />

Source : http://www.accessdata.fda.gov/scripts/cder/iig/index.cfm .<br />

a Examples of references using them are given.<br />

Number of Hits on<br />

FDA Homepage<br />

Other Names<br />

of Excipients<br />

COMPARISON AND SUMMARY OF DIFFERENT TECHNOLOGIES<br />

The main principles for oral extended drug release reviewed here are the<br />

membrane - coated reservoir systems <strong>and</strong> hydrophilic or hydrophobic matrix systems.<br />

They all have advantages <strong>and</strong> drawbacks <strong>and</strong> Table 3 summarizes some aspects of<br />

the different formulation principles.<br />

There are a number of commercial variants of the above - mentioned principles.<br />

Examples of commercial matrix - based formulations can be found in a review by<br />

Varma et al. [137] . One of the oldest commercial hydrophilic matrix systems is<br />

12<br />

4<br />

4<br />

3<br />

3<br />

3<br />

1<br />

1<br />

Hypromellose,<br />

HPMC,<br />

MHPC<br />

HPC<br />

PEO<br />

Carbopol,<br />

polyacrylic<br />

acid<br />

MC

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!